Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles

Akira Ito, Masashige Shinkai, Hiroyuki Honda, Kazuhiro Yoshikawa, Shinsuke Saga, Toshihiko Wakabayashi, Jun Yoshida, Takeshi Kobayashi

Research output: Contribution to journalArticle

108 Citations (Scopus)

Abstract

In this study we demonstrated that heat shock protein (HSP) 70 expression by hyperthermia induced antitumor immunity in the T-9 rat glioma. Our hyperthermic system using magnetic nanoparticles induced necrotic cell death that correlated with HSP70 expression. We purified the HSP70-peptide complexes from the tumor after hyperthermia to investigate whether HSP70 was involved in the antitumor immunity, and we found that in the F344 rats immunized with T-9-derived HSP70 the tumor growth of T-9 was significantly suppressed. Tumor rejection assay after hyperthermic treatment of implanted T-9 cells with incorporated magnetite cationic liposomes (MCL) was performed to investigate whether antitumor immunity was induced by release of HSP70 from the necrotic cells in the F344 rat. Tumor growth was strongly suppressed in the rats subjected to hyperthermia of implanted T-9 cells, and 50% of rats were protected from challenge with T-9 cells. Immunogenicity was enhanced when the HSP70-overexpressing T-9 cells were killed via necrosis in rats by hyperthermia, after which all rats were completely protected from challenge with T-9 cells. Our hyperthermic system produces vaccination with HSP70-peptide via necrotic tumor cell death in vivo, resulting in antitumor immunity. This phenomenon, which may be termed in situ vaccination, has important implications for the development of novel antitumor therapies.

Original languageEnglish
Pages (from-to)80-88
Number of pages9
JournalCancer Immunology, Immunotherapy
Volume52
Issue number2
Publication statusPublished - Feb 1 2003

Fingerprint

Magnetite Nanoparticles
HSP70 Heat-Shock Proteins
Immunity
Fever
Inbred F344 Rats
Neoplasms
Vaccination
Cell Death
Ferrosoferric Oxide
Peptides
Induced Hyperthermia
Growth
Liposomes
Glioma
Nanoparticles
Necrosis
Therapeutics

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Oncology
  • Cancer Research

Cite this

Ito, A., Shinkai, M., Honda, H., Yoshikawa, K., Saga, S., Wakabayashi, T., ... Kobayashi, T. (2003). Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunology, Immunotherapy, 52(2), 80-88.

Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. / Ito, Akira; Shinkai, Masashige; Honda, Hiroyuki; Yoshikawa, Kazuhiro; Saga, Shinsuke; Wakabayashi, Toshihiko; Yoshida, Jun; Kobayashi, Takeshi.

In: Cancer Immunology, Immunotherapy, Vol. 52, No. 2, 01.02.2003, p. 80-88.

Research output: Contribution to journalArticle

Ito, A, Shinkai, M, Honda, H, Yoshikawa, K, Saga, S, Wakabayashi, T, Yoshida, J & Kobayashi, T 2003, 'Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles', Cancer Immunology, Immunotherapy, vol. 52, no. 2, pp. 80-88.
Ito, Akira ; Shinkai, Masashige ; Honda, Hiroyuki ; Yoshikawa, Kazuhiro ; Saga, Shinsuke ; Wakabayashi, Toshihiko ; Yoshida, Jun ; Kobayashi, Takeshi. / Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. In: Cancer Immunology, Immunotherapy. 2003 ; Vol. 52, No. 2. pp. 80-88.
@article{4556f8ebdf59424dada4433643aeadc3,
title = "Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles",
abstract = "In this study we demonstrated that heat shock protein (HSP) 70 expression by hyperthermia induced antitumor immunity in the T-9 rat glioma. Our hyperthermic system using magnetic nanoparticles induced necrotic cell death that correlated with HSP70 expression. We purified the HSP70-peptide complexes from the tumor after hyperthermia to investigate whether HSP70 was involved in the antitumor immunity, and we found that in the F344 rats immunized with T-9-derived HSP70 the tumor growth of T-9 was significantly suppressed. Tumor rejection assay after hyperthermic treatment of implanted T-9 cells with incorporated magnetite cationic liposomes (MCL) was performed to investigate whether antitumor immunity was induced by release of HSP70 from the necrotic cells in the F344 rat. Tumor growth was strongly suppressed in the rats subjected to hyperthermia of implanted T-9 cells, and 50{\%} of rats were protected from challenge with T-9 cells. Immunogenicity was enhanced when the HSP70-overexpressing T-9 cells were killed via necrosis in rats by hyperthermia, after which all rats were completely protected from challenge with T-9 cells. Our hyperthermic system produces vaccination with HSP70-peptide via necrotic tumor cell death in vivo, resulting in antitumor immunity. This phenomenon, which may be termed in situ vaccination, has important implications for the development of novel antitumor therapies.",
author = "Akira Ito and Masashige Shinkai and Hiroyuki Honda and Kazuhiro Yoshikawa and Shinsuke Saga and Toshihiko Wakabayashi and Jun Yoshida and Takeshi Kobayashi",
year = "2003",
month = "2",
day = "1",
language = "English",
volume = "52",
pages = "80--88",
journal = "Cancer Immunology and Immunotherapy",
issn = "0340-7004",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "2",

}

TY - JOUR

T1 - Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles

AU - Ito, Akira

AU - Shinkai, Masashige

AU - Honda, Hiroyuki

AU - Yoshikawa, Kazuhiro

AU - Saga, Shinsuke

AU - Wakabayashi, Toshihiko

AU - Yoshida, Jun

AU - Kobayashi, Takeshi

PY - 2003/2/1

Y1 - 2003/2/1

N2 - In this study we demonstrated that heat shock protein (HSP) 70 expression by hyperthermia induced antitumor immunity in the T-9 rat glioma. Our hyperthermic system using magnetic nanoparticles induced necrotic cell death that correlated with HSP70 expression. We purified the HSP70-peptide complexes from the tumor after hyperthermia to investigate whether HSP70 was involved in the antitumor immunity, and we found that in the F344 rats immunized with T-9-derived HSP70 the tumor growth of T-9 was significantly suppressed. Tumor rejection assay after hyperthermic treatment of implanted T-9 cells with incorporated magnetite cationic liposomes (MCL) was performed to investigate whether antitumor immunity was induced by release of HSP70 from the necrotic cells in the F344 rat. Tumor growth was strongly suppressed in the rats subjected to hyperthermia of implanted T-9 cells, and 50% of rats were protected from challenge with T-9 cells. Immunogenicity was enhanced when the HSP70-overexpressing T-9 cells were killed via necrosis in rats by hyperthermia, after which all rats were completely protected from challenge with T-9 cells. Our hyperthermic system produces vaccination with HSP70-peptide via necrotic tumor cell death in vivo, resulting in antitumor immunity. This phenomenon, which may be termed in situ vaccination, has important implications for the development of novel antitumor therapies.

AB - In this study we demonstrated that heat shock protein (HSP) 70 expression by hyperthermia induced antitumor immunity in the T-9 rat glioma. Our hyperthermic system using magnetic nanoparticles induced necrotic cell death that correlated with HSP70 expression. We purified the HSP70-peptide complexes from the tumor after hyperthermia to investigate whether HSP70 was involved in the antitumor immunity, and we found that in the F344 rats immunized with T-9-derived HSP70 the tumor growth of T-9 was significantly suppressed. Tumor rejection assay after hyperthermic treatment of implanted T-9 cells with incorporated magnetite cationic liposomes (MCL) was performed to investigate whether antitumor immunity was induced by release of HSP70 from the necrotic cells in the F344 rat. Tumor growth was strongly suppressed in the rats subjected to hyperthermia of implanted T-9 cells, and 50% of rats were protected from challenge with T-9 cells. Immunogenicity was enhanced when the HSP70-overexpressing T-9 cells were killed via necrosis in rats by hyperthermia, after which all rats were completely protected from challenge with T-9 cells. Our hyperthermic system produces vaccination with HSP70-peptide via necrotic tumor cell death in vivo, resulting in antitumor immunity. This phenomenon, which may be termed in situ vaccination, has important implications for the development of novel antitumor therapies.

UR - http://www.scopus.com/inward/record.url?scp=0037298180&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037298180&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 80

EP - 88

JO - Cancer Immunology and Immunotherapy

JF - Cancer Immunology and Immunotherapy

SN - 0340-7004

IS - 2

ER -